References
- Klerman GL, Weissman MM. Increasing rates of depression. JAMA 1989;261:2229–35
- Chiu E. Epidemiology of depression in the Asia Pacific region. Australas Psychiatry 2004;12(Suppl):S4–10
- Jang Y, Small BJ, Haley WE. Cross-cultural comparability of the Geriatric Depression Scale: comparison between older Koreans and older Americans. Aging Ment Health 2001;5:31–7
- Preskorn SH. Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor. J Psychiatr Pract 2004;10:119–26
- Boyer P, Briley M. Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor. Drugs Today (Barc) 1998;34: 709–20
- Puech A, Montgomery SA, Prost JF, Solles A, Briley M. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int Clin Psychopharmacol 1997;12:99–108
- Tajima O. Japanese experience with dual-action antidepressants. Int Clin Psychopharmacol 2002;17(Suppl 1):S37–42
- Kasper S, Pletan Y, Solles A, Tournoux A. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. Int Clin Psychopharmacol 1996;11(Suppl 4):35–9
- Puozzo C, Leonard BE. Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol 1996;11(Suppl 4):15–27
- Sawada Y, Ohtani H. Pharmacokinetics and drug interactions of antidepressive agents. Nippon Rinsho 2001;59:1539–45
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;12:56–62
- Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9
- Guy W (Ed). ECDEU Assessment Manual for Psychopharmacology (revised). Rockville, MD. National Institute for Mental Health, Psychopharmacology Research Branch, 1976
- Covi L, Lipman RS, McNair DM, Czerlinsky T. Symptomatic volunteers in multicenter drug trials. Prog Neuropsychopharmacol 1979;3:521–33
- Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001;57:161–78
- Thase ME. Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry 2003;64(Suppl 2):3–7
- Guelfi JD, Ansseau M, Corruble E, Samuelian JC, Tonelli I, Tournoux A, Pletan Y. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. Int Clin Psychopharmacol 1998;13:121–8
- Clerc G, Milnacipran/Fluvoxamine Study Group. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. Int Clin Psychopharmacol 2001;16:145–51
- Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF. Milnacipran and selective serotonin reuptake inhibitors in major depression. Int Clin Psychopharmacol 1996;1\(Suppl 4): 41–6